Skip to main content

Table 3 Overview of false negative cases in NIPT. cFTS, combined first-trimester screening

From: Application of non-invasive prenatal testing in screening chromosomal aberrations in pregnancies with different nuchal translucency cutoffs

Case

Maternal age (y)

NT (mm)

Other chromosome diagnosis indication

Chromosome diagnosis time

Chromosome diagnosis result

1

26

3.0

Seizures appeared 20 days after birth

Postnatal

CDKL5 c.1136_1139 del TG

2

34

3.0

None

Prenatal

arr[GRCh37] 14q11.2q31.2 × 2 hmz, 63.815Mb, arr[GRCh37] 14q31.2q32.33 × 2 htz, 22.939Mb

3

30

3.2

High-risk in cFTS

Prenatal

arr[GRCh37]16p11.2 × 1, 597kb

4

33

3.3

High-risk in Cfts Abnormal ultrasound finding (cystic hygroma; nasal bone dysplasia)

Prenatal

arr[GRCh37] 9q34.3 × 1, 332Kb

5

33

3.7

High-risk in cFTS

Prenatal

arr[GRCh37] 16p11.2 × 1, 761 Kb

6

26

3.8

Abnormal developmental assessment at 18 months

Postnatal

arr[GRCh37] 15q11.2q13.1 × 1, 6.22Mb

7

33

4.6

High-risk in cFTS

Prenatal

47,XN, + 21

8

30

4.9

Abnormal ultrasound finding (aberrant left subclavian artery, dextro-aortic arch)

Prenatal

arr[GRCh37]22q11.21 × 1, 3.152Mb

9

27

5.2

High-risk in cFTS

Prenatal

arr[GRCh37]Xp21.1 × 2, 628kb, including Duchenne muscular dystrophy gene

10

30

5.9

Abnormal ultrasound finding (right clubfeet)

Prenatal

arr[GRCh37]9q21.33q31.2 × 1, 20.376 Mb